Milrinone in persistent pulmonary hypertension of newborn: a scoping review.
Journal
Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714
Informations de publication
Date de publication:
14 May 2024
14 May 2024
Historique:
received:
17
11
2023
accepted:
15
04
2024
revised:
06
04
2024
medline:
15
5
2024
pubmed:
15
5
2024
entrez:
14
5
2024
Statut:
aheadofprint
Résumé
Persistent pulmonary hypertension of the newborn (PPHN) is a common neonatal condition in newborns admitted to the neonatal intensive care units (NICUs). PPHN has still a high mortality and morbidity. Inhaled nitric oxide (iNO) is the first line vasodilator therapy for PPHN in high income countries. In low-to-middle income countries (LMICs), availability of iNO remains scarce and expensive. The purpose of this scoping review was to evaluate the current existing literature for milrinone therapy in PPHN and to identify the knowledge gaps in milrinone use in infants with PPHN. The available evidence for milrinone remains limited both as monotherapy and as an adjuvant to iNO. The studies were heterogeneous, conducted in different settings, with different populations and more importantly the endpoints of these trials were short-term outcomes such as changes in oxygenation and blood pressure. Large prospective studies investigating long-term outcomes, mortality, and the need for Extracorporeal membrane oxygenation (ECMO) are warranted. Randomized controlled trials with milrinone as monotherapy are needed in LMICs where iNO availability remains limited. IMPACT: Milrinone has a potential role in the management of PPHN both as an adjuvant to iNO as well as a monotherapy. This scoping review identified the problems existing in the published literature on milrinone and the barriers to generalization of these results. Multi-centre randomized controlled trials on milrinone, especially involving centers from low- and middle-income countries are needed, where it can be evaluated as first-line pulmonary vasodilator therapy.
Identifiants
pubmed: 38745027
doi: 10.1038/s41390-024-03234-z
pii: 10.1038/s41390-024-03234-z
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.
Références
Lakshminrusimha, S. & Keszler, M. Persistent pulmonary hypertension of the newborn. Neoreviews 16, e680–e692 (2015).
doi: 10.1542/neo.16-12-e680
pubmed: 26783388
pmcid: 4714607
Zhou, R., Zheng, Y.-N., Zhang, X.-Y. & Cheng, Y.-Y. A meta-analysis of the risk factors of persistent pulmonary hypertension in newborns. Front. Pediatr. 9, 659137 (2021).
doi: 10.3389/fped.2021.659137
pubmed: 34778120
pmcid: 8585993
Galambos, C. et al. Phenotype characterisation of Tbx4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension. Eur. Respir. J. 54, 1801965 (2019).
doi: 10.1183/13993003.01965-2018
pubmed: 31151956
Martinho, S., Adão, R., Leite-Moreira, A. F. & Brás-Silva, C. Persistent pulmonary hypertension of the newborn: pathophysiological mechanisms and novel therapeutic approaches. Front. Pediatr. 8, 342 (2020).
doi: 10.3389/fped.2020.00342
pubmed: 32850518
pmcid: 7396717
Davidson, D. et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group. Pediatrics 101, 325–334 (1998).
doi: 10.1542/peds.101.3.325
pubmed: 9480993
Clark, R. H. et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N. Engl. J. Med. 342, 469–474 (2000).
doi: 10.1056/NEJM200002173420704
pubmed: 10675427
Baquero, H., Soliz, A., Neira, F., Venegas, M. E. & Sola, A. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 117, 1077–1083 (2006).
doi: 10.1542/peds.2005-0523
pubmed: 16585301
Vargas-Origel, A. et al. The use of sildenafil in persistent pulmonary hypertension of the newborn. Am. J. Perinatol. 27, 225–230 (2010).
doi: 10.1055/s-0029-1239496
pubmed: 19866403
McNamara, P. J., Shivananda, S. P., Sahni, M., Freeman, D. & Taddio, A. Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide. Pediatr. Crit. Care Med. 14, 74–84 (2013).
doi: 10.1097/PCC.0b013e31824ea2cd
pubmed: 23132395
Bassler, D., Choong, K., McNamara, P. & Kirpalani, H. Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol. Neonate 89, 1–5 (2006).
doi: 10.1159/000088192
pubmed: 16155380
Tricco, A. C. et al. Prisma extension for scoping reviews (PRISMA-Scr): checklist and explanation. Ann. Intern. Med. 169, 467–473 (2018).
doi: 10.7326/M18-0850
pubmed: 30178033
Imam, S. S., El-Farrash, R. A., Taha, A. S. & Saleh, G. A. Milrinone versus sildenafil in treatment of neonatal persistent pulmonary hypertension: a randomized control trial. J. Cardiovasc. Pharmacol. 80, 746–752 (2022).
doi: 10.1097/FJC.0000000000001332
pubmed: 35881893
El-Ghandour, M., Hammad, B., Ghanem, M. & Antonios, M. A. M. Efficacy of milrinone plus sildenafil in the treatment of neonates with persistent pulmonary hypertension in resource-limited settings: results of a randomized, double-blind trial. Pediatr. Drugs 22, 685–693 (2020).
doi: 10.1007/s40272-020-00412-4
Bagheri, M. M., Ebrahimpour, M., Amirzadeh, R. & Derakhshan, R. Comparison of the efficacy of milrinone injection versus milrinone plus oral sildenafil in newborns with pulmonary arterial hypertension. J. Kerman Univ. Med. Sci. 28, 1–9 (2021).
Rahman, M., Nupur, N. R., Mamun, M. A. A. & Hossain, M. M. Comparison of efficacy between sildenafil alone and sildenafil with milrinone for treatment of persistent pulmonary hypertension of the newborn. Scholars J. Appl. Med. Sci. 9, 1525–1532 (2021).
doi: 10.36347/sjams.2021.v09i10.008
Sardar, S., Pal, S. & Mishra, R. A retrospective study on the profile of persistent pulmonary hypertension of newborn in a tertiary care unit of Eastern India. J. Clin. Neonatol. 9, 18–26 (2020).
doi: 10.4103/jcn.JCN_68_19
James, A. T., Corcoran, J. D., McNamara, P. J., Franklin, O. & El-Khuffash, A. F. The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension. Cardiol. Young 26, 90–99 (2016).
doi: 10.1017/S1047951114002698
pubmed: 25599873
McNamara, P. J., Laique, F., Muang-In, S. & Whyte, H. E. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J. Crit. Care 21, 217–222 (2006).
doi: 10.1016/j.jcrc.2006.01.001
pubmed: 16769471
Dillard, J., Pavlek, L. R., Korada, S. & Chen, B. Worsened short-term clinical outcomes in a cohort of patients with iNO-unresponsive PPHN: a case for improving ino responsiveness. J. Perinatol. 42, 37–44 (2022).
doi: 10.1038/s41372-021-01228-x
pubmed: 34654904
El-Khuffash, A. et al. The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (Mint 1). J. Perinatol. 43, 168–173 (2023).
doi: 10.1038/s41372-022-01562-8
pubmed: 36385642
Choobdar, F. A. et al. Comparison of the efficacy of inhaled versus infused milrinone in the management of persistent pulmonary hypertension of the newborn in resource-limited settings: a randomized clinical trial. Pediatr. Pulmonol. 58, 2132–2139 (2023).
doi: 10.1002/ppul.26451
pubmed: 37133219
Hoffman, T. M. et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107, 996–1002 (2003).
doi: 10.1161/01.CIR.0000051365.81920.28
pubmed: 12600913
Lakshminrusimha, S. et al. Milrinone in congenital diaphragmatic hernia - a randomized pilot trial: study protocol, review of literature and survey of current practices. Matern. Health Neonatol. Perinatol. 3, 27 (2017).
doi: 10.1186/s40748-017-0066-9
pubmed: 29209510
pmcid: 5704584
Schouten, E. et al. Standardized outcome measures for preterm and hospitalized neonates: an ICHOM standard set. Neonatology 119, 443–454 (2022).
doi: 10.1159/000522318
pubmed: 35545018